Innovation and Firm Growth: Is R&D Worth It?

198 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The risk-reward nexus in the innovation-inequality relationship: who takes the risks? Who gets the rewards? (2013, background): “…government spending and the business funding that has flowed into the biopharmaceutical industry through private equity (including venture capital), IPOs, secondary stock issues, and R&D contracts, the biopharmaceutical industry has not been productive (Pisano, 2006; Demirel and Mazzucato, 2012).”
Innovation and firm growth: Does firm age play a role? (2016, unknown): “In fact, for growth of labour productivity and employment, we observe a negative impact for the lowest quantiles, which suggests that R&D investment is not always successful (Demirel and Mazzucato, 2012; Nunes et al., 2012).”
The Role of Human Capital in Lowering the Barriers to Engaging in Innovation: Evidence from the Spanish Innovation Survey (2014, background): “2.1 Identifying firms that face deterring and revealed barriers to innovation Innovation has for long been recognized as a vital contributor to the economic performance and survival of firms (Cefis and Marsili, 2005; Coad and Rao, 2008; Demirel and Mazzucato, 2012).”
The drivers of SME innovation in the regions of the EU (2021, background): “SMEs are particularly disadvantaged by this target, which generally benefits larger firms (Demirel and Mazzucato, 2012).”